Dechra to acquire Dutch firms AST Farma and Le Vet
Dechra Pharmaceuticals has announced that it is buying two Dutch businesses, AST Farma and Le Vet, for a combined €340m. AST Farma is one of the leading companion animal pharmaceutical companies in the Netherlands, focusing on generic and generic plus products. Le Vet concentrates on European markets outside of the Netherlands and has worked with AST Farma to develop its product portfolio and establish a network of marketing partners across Europe, which includes Dechra. Together the companies hold around 90 product registrations. To fund the deal, Dechra has announced a share placing that will raise £100m, with the remaining 75% to be paid in cash.